General and efficient strategy for erythrinan and homoerythrinan alkaloids: Syntheses of (±)-3-demethoxyerythratidinone and (±)- erysotramidine

Organic Letters

Volumn 8, Issue 11, 2006, Pages 2373-2376

  Gao, Shuanhu ^a   Tu, Yong Qiang ^a   Hu, Xiangdong ^a   Wang, Shaohua ^a   Hua, Rongbao ^a   Jiang, Yijun ^a   Zhao, Yuming ^a   Fan, Xiaohui ^a   Zhang, Shuyu ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEMETHOXYERYTHRATIDINONE; 3-DEMETHOXYERYTHRATIDINONE; ALKALOID; ERYSOTRAMIDINE; FUSED HETEROCYCLIC RINGS; INDOLE ALKALOID;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; ERYTHRINA; STEREOISOMERISM; SYNTHESIS;

ALKALOIDS; ERYTHRINA; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; INDOLE ALKALOIDS; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 33745725808     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0607185     Document Type: Article

References (40)

1. (a) Tanaka, H.; Tanaka, T.; Etoh, H.; Goto, S.; Terada, Y. Heterocycles 1999, 51, 2759-2764.
2. (b) Dyke, S. F.; Quessy, S. N. In The Alkaloids; Rodrigo, R. G. A., Ed.; Academic Press: New York, 1981; Vol. 18. pp 1-98.
3. Tsuda, Y.; Sano, T. In The Alkaloids; Cordell, G. A., Ed.; Academic Press: San Diego, 1996; Vol. 48, pp 249-337.
4. Kawasaki, T.; Onoda, N.; Watanabe, H.; Kitahara, T. Tetrahedron Lett. 2001, 42, 8003.
5. (a) Wang, Q.; Padwa, A. Org. Lett. 2006, 8, 601.
6. (b) Kim, G.; Kim, J. H.; Lee, K. Y. J. Org. Chem. 2006, 71, 2185.
7. (c) Cassidy, M. P.; Özdemir, A. D.; Padwa, A. Org. Lett. 2005, 7, 1339.
8. (d) Lee, H. I.; Cassidy, M. P.; Rashatasakhon, P.; Padwa, A. Org. Lett. 2003, 5, 5067.
9. (e) Belleau, B. J. Am. Chem. Soc. 1953, 75, 5765.
10. (f) Mondon, A.; Hansen, K. F. Tetrahedron Lett. 1960, 5.
11. (g) Ishibashi, H.; Sato, T.; Takahashi, M.; Hayashi, M.; Ikeda, M. Heterocycles 1988, 27, 2787.
12. (h) Tsuda, Y.; Hosoi, S.; Ishida, K.; Sangai, M. Chem. Pharm. Bull. 1994, 42, 204.
13. (i) Cassayre, J.; Quiclet-Sire, B.; Saunier, J.-B.; Zard, S. Z. Tetrahedron Lett. 1998, 39, 8995.
14. (j) Rigby, J. H.; Deur, C.; Heeg, M. J. Tetrahedron Lett. 1999, 40, 6887.
15. (k) Toyao, A.; Chikaoka, S.; Takeda, Y.; Tamura, O.; Muraoka, O.; Tanabe, G.; Ishibashi, H. Tetrahedron Lett. 2001, 42, 1729.
16. (l) Miranda, L. D.; Zard, S. Z. Org. Lett. 2002, 4, 1135.
17. (m) Allin, S. M.; James, S. L.; Elsegood, M. R. J.; Martin, W. P. J. Org. Chem. 2002, 67, 9464.
18. (n) Toda, J.; Niimura, Y.; Takeda, K.; Sano, T.; Tsuda, Y. Chem. Pharm. Bull. 1998, 46, 906.
19. (o) Jousse, C.; Demaele, D. Eur. J. Org. Chem. 1999, 909 and references therein.
20. (p) Parsons, A. F.; Williams, D. A. Tetrahedron 2000, 56, 7217.
21. (a) Danishefsky, S. J.; Panek, J. S. J. Am. Chem. Soc. 1987, 109, 917.
22. (b) Ahmed-Schofield, R.; Mariano, P. S. J. Org. Chem. 1987, 52, 1478.
23. (c) Irie, H.; Shibata, K.; Matsuno, K.; Zhang, Y. Heterocycles 1989, 29, 1033.
24. (d) Kawasaki, T.; Onoda, N.; Watanabe, H.; Kitahara, T. Tetrahedron Lett. 2001, 42, 8003 and references therein.
25. (a) Wasserman, H. H.; Amid, R. M. J. Org. Chem. 1989, 54, 5843.
26. (b) Sano, T.; Toda, J.; Kashiwaba, N.; Ohshima, T.; Tsuda, Y. Chem. Pharm. Bull. 1987, 35, 479.
27. (c) Tsuda, Y.; Hosoi, S.; Katagiri, N.; Kaneko, C.; Sano, T. Heterocycles 1992, 33, 497 and references therein.
28. Maryanoff, B. E.; Zhang, H. C.; Cohen, J. H.; Turchi, I. J.; Maryanoff, C. A. Chem. Rev. 2004, 104, 1431.
29. (a) Bonjoch, J.; Catena, J.; Valls, N. J. Org. Chem. 1996, 61, 7106.
30. (b) Dufour, M.; Gramain, J. C.; Husson, H. P.; Sinibaldi, M. E.; Troin, Y. J. Org. Chem. 1990, 55, 5483.
31. N-Arylethylhydroindole 14 can also be prepared directly from β-keto ester and N-substituted iodoacetaraide 9 (see details in Supporting Information).
32. N-Arylethylhydroindole as only one single isomer was isolated in this transformation, and its relative configuration was not further confirmed because it was eliminated in the next step, N-acyliminium ion promoted intramolecur cyclization.
33. Cis-fused furan-type erythrinan 32 has been used for the construction of the β-erythroidine skeleton as a key intermediate. See: (a) Isobe, K.; Mohri, K.; Itoh, Y.; Toyokawa, Y.; Takeda, N.; Taga, J.; Tsuda, Y. Chem. Pharm. Bull. 1987, 35, 2618.
34. (b) Sano, T.; Toda, J.; Yamamoto, R.; Shoda, M.; Isobe, K.; Tsuda, Y. Chem. Pharm. Bull. 1992, 40, 2663.
35. (a) Tanis, S. P.; Dixon, L. A. Tetrahedron Lett. 1987, 28, 2495.
36. (b) Tanis, S. P.; Deaton, M. V.; Dixon, L. A.; Mcmills, M. C.; Raggon, J. W.; Collins, M. A. J. Org. Chem. 1998, 63, 6419 and references therein.
37. (a) Ishibashi, H.; Harada, S.; Sato, K.; Ikeda, M.; Akai, S.; Tamura, Y. Chem. Pharm. Bull. 1985, 33, 5278.
38. (b) Tsuda, Y.; Sakai, Y.; Nakai, A.; Kaneko, M.; Ishiguro, Y.; Isobe, J.; Taga, J.; Sano, T. Chem. Pharm. Bull. 1990, 38, 1462.
39. (c) Tsuda, Y.; Ohshima, T.; Sano, T.; Toda, J. Heterocycles 1982, 19, 2053.
40. (d) Tanaka, H.; Tamura, M.; Shibata, M.; Ito, K. Chem. Pharm. Bull. 1986, 34, 24.